This was from the October 6th press release. ".
Post# of 5066
Quote:
"...efficacy, manufacturing, and agreement on trial design, all of which we have come to agreement with the regulators on," said Thomas Ichim, Ph.D.,
He goes on to say
Quote:
"The current discussions with the FDA are about which test system is most reliable for demonstrating safety
I believe an update about HemaXellerate is very very soon.